Skip to main content

Illumina, Mount Sinai Services to Offer Verifi NIPT in Ontario

NEW YORK (GenomeWeb) – Mount Sinai Services today announced a distribution deal with Illumina to offer the Verifi non-invasive prenatal test in Ontario.

Mount Sinai Services said that the deal also provides it flexibility to offer the test in other regions in Canada. Financial and other terms of the deal were not disclosed. Illumina acquired the Verifi test when it purchased Verinata Health in 2013.

Verifi detects trisomies 21, 18, and 13, as well as sex chromosomes for monosomy X, Triple X syndrome, Klinefelter syndrome, and Jacobs syndrome. Additionally, the test helps to stratify the risk for certain X-linked disorders, such as hemophilia, Duchenne muscular dystrophy, or cases of ambiguous genitalia.

Mount Sinai Services is based in Toronto and provides customized laboratory and research services and works with Mount Sinai Hospital's laboratories, clinicians, and researchers.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.